Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on May 28, 2025
Global AI in Precision Medicine Market is Expected to Showcase a Significant Growth at a Massive CAGR of ~33% by 2032 | DelveInsight
GlobeNewswire
·
May 28, 2025
New York, USA, May 28, 2025 (GLOBE NEWSWIRE) -- Global AI in Precision Medicine Market is Expected to Showcase a Significant Growth at a Massive CAGR of ~33% by 2032 | DelveInsight The AI in precision medicine market is experiencing significant growth, …
NFL Standouts Bring the Conversation on Psychedelic Healing to Psychedelic Science 2025
GlobeNewswire
·
May 28, 2025
Jordan Poyer, Jon Feliciano, and Robert Gallery join Aubrey Marcus to share candid stories of healing, brotherhood, and the work they are doing now. Attendees will explore the emotional and neurological impact of elite competition—and discover how …
Calgary refugees have their healthcare services saved temporarily thanks to Calgary Health Foundation donors
GlobeNewswire
·
May 28, 2025
Calgary, Alberta, Canada, May 28, 2025 (GLOBE NEWSWIRE) -- Calgary Health Foundation is proud to announce a commitment to the Calgary Refugee Health Clinic, one that will secure its operations for the next two years. The $550K promise, made possible thanks …
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3
GlobeNewswire
·
May 28, 2025
HOUSTON, TX, May 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on June 3, 2025, at 4:15 p.m. ET. Attendees will gain an inside look at Nexalin’s game- …
Local Neurosurgeon Jeremy Denning Raises Awareness for National Scoliosis Month
GlobeNewswire
·
May 28, 2025
PLANO, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- June is National Scoliosis Awareness Month – an ideal time to explore causes and treatment methods for scoliosis, which affects approximately 7 million people in the United States, as reported by the National …
Intrommune Therapeutics Announces Independent Editorial Highlighting Breakthrough Safety Data for Novel Toothpaste Peanut Allergy Treatment
GlobeNewswire
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- As the burden of food allergies continues to increase each year, the need for safe, effective, and convenient treatments has never been greater. Over 33 million Americans suffer from food allergies, including …
Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (testosterone undecanoate) CIII Capsules Extending Coverage to 2040
GlobeNewswire
·
May 28, 2025
RALEIGH, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announced today that the United States Patent and Trademark Office (USPTO) for a new …
Distalmotion Gains FDA 510(k) Clearance for Cholecystectomy, Further Advancing Access to Robotics in the Outpatient Setting with its DEXTER® Robotic Surgery System
GlobeNewswire
·
May 28, 2025
Lausanne, Switzerland, May 28, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in more sites of care, today announced that it has received FDA 510(k) clearance for the use of its DEXTER …
Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada
GlobeNewswire
·
May 28, 2025
TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to award $85,000 to a groundbreaking research project led by Dr. Sheila Singh and her team at McMaster University. The project titled "Lamin B Receptor (LBR) as an Immunotherapeutic …
Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that the …
Vittoria Biotherapeutics to Share Trials-in-Progress Presentation from Phase 1 Study of VIPER-101 at ASCO 2025 Annual Meeting
GlobeNewswire
·
May 28, 2025
PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics Inc., a clinical-stage immunotherapy company specializing in the development of innovative therapies for hard-to-treat diseases, today announced it will present a trials-in-progress …
iTeos Therapeutics Announces Its Intention to Wind Down Operations
GlobeNewswire
·
May 28, 2025
- Board of Directors intends to cease operations - Company to focus efforts on selecting best path to deliver near-term value to shareholders - Exploring potential asset sales including EOS-984, EOS-215, and a preclinical obesity program targeting ENT1 …
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
GlobeNewswire
·
May 28, 2025
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold Resumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six months; as previously disclosed GSK …
Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that new data will be presented at the American Society …
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
4DMT to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 28, 2025
EMERYVILLE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …
genXtraits Inc. expands collaboration with The New Zealand Institute for Plant & Food Research Limited to increase vitamin C in crops, including corn and soybean
GlobeNewswire
·
May 28, 2025
ALAMEDA, Calif. , May 28, 2025 (GLOBE NEWSWIRE) -- genXtraits Inc. (genXtraits) today announced that it has expanded its license and collaboration agreement with The New Zealand Institute for Plant and Food Research Limited (Plant …
Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will present during the …
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that Akebia Executive Management will …
A Future Where Women’s Health Leads: The MUHC Foundation Launches $5 Million Movement for Change
GlobeNewswire
·
May 28, 2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Women deserve health care designed with them in mind. They deserve research that includes them, care that reflects their needs, and a future where their well-being is a top priority. Today, on this International …